Previous Article | Next Article 
Journal of Virology, May 2005, p. 6299-6311, Vol. 79, No. 10
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.10.6299-6311.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Distinct Mechanisms of CD4+ and CD8+ T-Cell Activation and Bystander Apoptosis Induced by Human Immunodeficiency Virus Type 1 Virions
Geoffrey H. Holm1 and
Dana Gabuzda1,2*
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute,1
Department of Neurology, Harvard Medical School, Boston, Massachusetts 021152
Received 19 August 2004/
Accepted 13 January 2005
Apoptosis of uninfected bystander T cells contributes to T-cell depletion during human immunodeficiency virus type 1 (HIV-1) infection. HIV-1 envelope/receptor interactions and immune activation have been implicated as contributors to bystander apoptosis. To better understand the relationship between T-cell activation and bystander apoptosis during HIV-1 pathogenesis, we investigated the effects of the highly cytopathic CXCR4-tropic HIV-1 variant ELI6 on primary CD4+ and CD8+ T cells. Infection of primary T-cell cultures with ELI6 induced CD4+ T-cell depletion by direct cell lysis and bystander apoptosis. Exposure of primary CD4+ and CD8+ T cells to nonreplicating ELI6 virions induced bystander apoptosis through a Fas-independent mechanism. Bystander apoptosis of CD4+ T cells required direct contact with virions and Env/CXCR4 binding. In contrast, the apoptosis of CD8+ T cells was triggered by a soluble factor(s) secreted by CD4+ T cells. HIV-1 virions activated CD4+ and CD8+ T cells to express CD25 and HLA-DR and preferentially induced apoptosis in CD25+HLA-DR+ T cells in a CXCR4-dependent manner. Maximal levels of binding, activation, and apoptosis were induced by virions that incorporated MHC class II and B7-2 into the viral membrane. These results suggest that nonreplicating HIV-1 virions contribute to chronic immune activation and T-cell depletion during HIV-1 pathogenesis by activating CD4+ and CD8+ T cells, which then proceed to die via apoptosis. This mechanism may represent a viral immune evasion strategy to increase viral replication by activating target cells while killing immune effector cells that are not productively infected.
* Corresponding author. Mailing address: Dana-Farber Cancer Institute, JFB 816, 44 Binney St., Boston, MA 02115. Phone: (617) 632-2154. Fax: (617) 632-3113. E-mail:
dana_gabuzda{at}dfci.harvard.edu.
Journal of Virology, May 2005, p. 6299-6311, Vol. 79, No. 10
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.10.6299-6311.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Feldmann, J., Leligdowicz, A., Jaye, A., Dong, T., Whittle, H., Rowland-Jones, S. L.
(2009). Downregulation of the T-Cell Receptor by Human Immunodeficiency Virus Type 2 Nef Does Not Protect against Disease Progression. J. Virol.
83: 12968-12972
[Abstract]
[Full Text]
-
Sivaraman, V., Zhang, L., Meissner, E. G., Jeffrey, J. L., Su, L.
(2009). The Heptad Repeat 2 Domain Is a Major Determinant for Enhanced Human Immunodeficiency Virus Type 1 (HIV-1) Fusion and Pathogenicity of a Highly Pathogenic HIV-1 Env. J. Virol.
83: 11715-11725
[Abstract]
[Full Text]
-
Alexander, L., Zhang, S., McAuliffe, B., Connors, D., Zhou, N., Wang, T., Agler, M., Kadow, J., Lin, P.-F.
(2009). Inhibition of Envelope-Mediated CD4+-T-Cell Depletion by Human Immunodeficiency Virus Attachment Inhibitors. Antimicrob. Agents Chemother.
53: 4726-4732
[Abstract]
[Full Text]
-
Byrnes, A. A., Harris, D. M., Atabani, S. F., Sabundayo, B. P., Langan, S. J., Margolick, J. B., Karp, C. L.
(2008). Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy. J. Leukoc. Biol.
84: 1447-1453
[Abstract]
[Full Text]
-
Stevceva, L., Yoon, V., Carville, A., Pacheco, B., Santosuosso, M., Korioth-Schmitz, B., Mansfield, K., Poznansky, M. C.
(2008). The Efficacy of T Cell-Mediated Immune Responses Is Reduced by the Envelope Protein of the Chimeric HIV-1/SIV-KB9 Virus In Vivo. J. Immunol.
181: 5510-5521
[Abstract]
[Full Text]
-
Zhou, Y., Shen, L., Yang, H.-C., Siliciano, R. F.
(2008). Preferential Cytolysis of Peripheral Memory CD4+ T Cells by In Vitro X4-Tropic Human Immunodeficiency Virus Type 1 Infection before the Completion of Reverse Transcription. J. Virol.
82: 9154-9163
[Abstract]
[Full Text]
-
Hu, H., Fernando, K., Ni, H., Weissman, D.
(2008). HIV Envelope Suppresses CD4+ T Cell Activation Independent of T Regulatory Cells. J. Immunol.
180: 5593-5600
[Abstract]
[Full Text]
-
Leong, A S-Y, Wannakrairot, P, Leong, T Y-M
(2008). Apoptosis is a major cause of so-called "caseous necrosis" in mycobacterial granulomas in HIV-infected patients. J. Clin. Pathol.
61: 366-372
[Abstract]
[Full Text]
-
Kim, N., Dabrowska, A., Jenner, R. G., Aldovini, A.
(2007). Human and Simian Immunodeficiency Virus-Mediated Upregulation of the Apoptotic Factor TRAIL Occurs in Antigen-Presenting Cells from AIDS-Susceptible but Not from AIDS-Resistant Species. J. Virol.
81: 7584-7597
[Abstract]
[Full Text]
-
Fernando, K., Hu, H., Ni, H., Hoxie, J. A., Weissman, D.
(2007). Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses. Blood
109: 2538-2544
[Abstract]
[Full Text]
-
Rodriguez, B., Sethi, A. K., Cheruvu, V. K., Mackay, W., Bosch, R. J., Kitahata, M., Boswell, S. L., Mathews, W. C., Bangsberg, D. R., Martin, J., Whalen, C. C., Sieg, S., Yadavalli, S., Deeks, S. G., Lederman, M. M.
(2006). Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.. JAMA
296: 1498-1506
[Abstract]
[Full Text]
-
Finzi, D., Plaeger, S. F., Dieffenbach, C. W.
(2006). Defective Virus Drives Human Immunodeficiency Virus Infection, Persistence, and Pathogenesis.. CVI
13: 715-721
[Full Text]
-
Paiardini, M., Cervasi, B., Sumpter, B., McClure, H. M., Sodora, D. L., Magnani, M., Staprans, S. I., Piedimonte, G., Silvestri, G.
(2006). Perturbations of Cell Cycle Control in T Cells Contribute to the Different Outcomes of Simian Immunodeficiency Virus Infection in Rhesus Macaques and Sooty Mangabeys. J. Virol.
80: 634-642
[Abstract]
[Full Text]
-
Beer, B. E., Brown, C. R., Whitted, S., Goldstein, S., Goeken, R., Plishka, R., Buckler-White, A., Hirsch, V. M.
(2005). Immunodeficiency in the Absence of High Viral Load in Pig-Tailed Macaques Infected with Simian Immunodeficiency Virus SIVsun or SIVlhoest. J. Virol.
79: 14044-14056
[Abstract]
[Full Text]